title: Drug updates and approvals: 2012 in review.
abstract: Each year, the FDA approves many pharmaceuticals and products designed to treat or improve a patient's condition. The following is a sampling of some of the most important drugs approved in 2012 that specifically apply to nurse practitioner practice.
authors.affiliation: University of Pittsburgh Medical Center-Presbyterian Hospital, Pittsburgh, PA, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Belavic
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D000069547:Cobicistat; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000068679:Emtricitabine; D005233:Fatty Alcohols / Q000627:therapeutic use; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D009722:Nurse Practitioners; D063065:Organophosphonates / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000627:therapeutic use; D011241:Prednisone / Q000737:chemistry / Q000627:therapeutic use; D011506:Proteins / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D000069579:Ranibizumab; D000068698:Tenofovir; D013844:Thiazoles / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D012176:Retinoids
chemical_list: D000083:Acetanilides; D000225:Adenine; D061067:Antibodies, Monoclonal, Humanized; D001552:Benzazepines; D002219:Carbamates; D000069547:Cobicistat; D003841:Deoxycytidine; D004338:Drug Combinations; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000068679:Emtricitabine; D005233:Fatty Alcohols; D015735:Mifepristone; D009539:Nicotinic Acids; D063065:Organophosphonates; D010715:Phosphatidylglycerols; D011241:Prednisone; D011506:Proteins; D011743:Pyrimidines; D015363:Quinolones; D000069579:Ranibizumab; D000068698:Tenofovir; D013844:Thiazoles; C502722:lucinactant; C509700:elvitegravir; C506658:lorcaserin; C086827:tazarotene; D012176:Retinoids; C553414:avanafil; C520025:mirabegron